Revolution Medicines, Inc. (RVMD) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
30/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 8 wins, 4 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinRVMD / S&P 92.58% / 15.20% |
LoseRVMD / S&P RVMD unavailable / 15.00% |
WinRVMD / S&P 96.23% / 50.40% |
| 2026-Q12/3 |
WinRVMD / S&P 22.10% / -4.33% |
LoseRVMD / S&P RVMD unavailable / 11.30% |
WinRVMD / S&P 77.06% / 27.70% |
| 2025-Q42/3 |
WinRVMD / S&P 70.56% / 2.65% |
LoseRVMD / S&P RVMD unavailable / 9.00% |
WinRVMD / S&P 65.92% / 13.40% |
| 2025-Q32/3 |
WinRVMD / S&P 26.94% / 8.12% |
LoseRVMD / S&P RVMD unavailable / 4.61% |
WinRVMD / S&P 41.53% / 13.45% |
| 2025-Q21/3 |
LoseRVMD / S&P 4.04% / 10.94% |
LoseRVMD / S&P RVMD unavailable / 4.83% |
WinRVMD / S&P 21.56% / 10.63% |
| 2025-Q10/3 |
LoseRVMD / S&P -19.16% / -4.27% |
LoseRVMD / S&P RVMD unavailable / 4.98% |
LoseRVMD / S&P 4.97% / 10.57% |
| 2024-Q40/3 |
LoseRVMD / S&P -3.55% / 2.41% |
LoseRVMD / S&P -100.00% / 5.25% |
LoseRVMD / S&P -6.77% / 6.15% |
| 2024-Q32/3 |
WinRVMD / S&P 16.85% / 5.89% |
LoseRVMD / S&P -97.16% / 5.89% |
WinRVMD / S&P 12.96% / 6.11% |
| 2024-Q22/3 |
WinRVMD / S&P 20.42% / 4.28% |
LoseRVMD / S&P -97.49% / 5.38% |
WinRVMD / S&P 18.91% / 5.12% |
| 2024-Q12/3 |
WinRVMD / S&P 12.38% / 10.56% |
LoseRVMD / S&P -86.89% / 5.71% |
WinRVMD / S&P 26.49% / 5.59% |
| 2023-Q41/3 |
LoseRVMD / S&P 3.61% / 11.69% |
LoseRVMD / S&P -67.27% / 6.81% |
WinRVMD / S&P 24.68% / 7.78% |
| 2023-Q32/3 |
WinRVMD / S&P 3.48% / -3.27% |
LoseRVMD / S&P -11.32% / 7.52% |
WinRVMD / S&P 1.57% / -5.03% |
| 2023-Q22/3 |
WinRVMD / S&P 23.50% / 8.74% |
LoseRVMD / S&P 8.33% / 9.50% |
WinRVMD / S&P 2.63% / -8.57% |
| 2023-Q12/3 |
LoseRVMD / S&P -9.07% / 7.50% |
WinRVMD / S&P 29.73% / 10.77% |
WinRVMD / S&P 7.09% / -15.69% |
| 2022-Q42/3 |
WinRVMD / S&P 20.79% / 7.56% |
WinRVMD / S&P 20.38% / 11.88% |
LoseRVMD / S&P RVMD unavailable / -17.99% |
| 2022-Q31/3 |
WinRVMD / S&P 1.18% / -4.88% |
LoseRVMD / S&P 2.89% / 13.47% |
LoseRVMD / S&P RVMD unavailable / -1.41% |
| 2022-Q20/3 |
LoseRVMD / S&P -23.60% / -16.10% |
LoseRVMD / S&P -32.27% / 13.71% |
LoseRVMD / S&P RVMD unavailable / 11.04% |
| 2022-Q11/3 |
WinRVMD / S&P 1.35% / -4.60% |
LoseRVMD / S&P -35.44% / 15.97% |
LoseRVMD / S&P RVMD unavailable / 42.23% |
| 2021-Q40/3 |
LoseRVMD / S&P -8.51% / 11.03% |
LoseRVMD / S&P -31.62% / 15.00% |
LoseRVMD / S&P RVMD unavailable / 96.40% |
| 2021-Q30/3 |
LoseRVMD / S&P -13.33% / 0.58% |
LoseRVMD / S&P -38.08% / 10.77% |
LoseRVMD / S&P RVMD unavailable / 69.42% |
| 2021-Q20/3 |
LoseRVMD / S&P -30.82% / 8.55% |
LoseRVMD / S&P -12.83% / 6.58% |
LoseRVMD / S&P RVMD unavailable / 51.81% |
| 2021-Q11/3 |
WinRVMD / S&P 15.89% / 6.17% |
LoseRVMD / S&P -14.15% / -1.06% |
LoseRVMD / S&P RVMD unavailable / 7.39% |
| 2020-Q41/3 |
WinRVMD / S&P 13.76% / 12.15% |
LoseRVMD / S&P -14.10% / -3.72% |
LoseRVMD / S&P RVMD unavailable / -33.42% |
| 2020-Q31/3 |
WinRVMD / S&P 10.23% / 8.93% |
LoseRVMD / S&P RVMD unavailable / -2.04% |
LoseRVMD / S&P RVMD unavailable / -27.10% |
| 2020-Q21/3 |
WinRVMD / S&P 44.09% / 20.54% |
LoseRVMD / S&P RVMD unavailable / -0.46% |
LoseRVMD / S&P RVMD unavailable / -27.11% |
| 2020-Q10/3 |
LoseRVMD / S&P RVMD unavailable / -19.60% |
LoseRVMD / S&P RVMD unavailable / 3.47% |
LoseRVMD / S&P RVMD unavailable / -14.75% |
| 2019-Q40/3 |
LoseRVMD / S&P RVMD unavailable / 9.07% |
LoseRVMD / S&P RVMD unavailable / 5.36% |
LoseRVMD / S&P RVMD unavailable / 2.99% |
| 2019-Q30/3 |
LoseRVMD / S&P RVMD unavailable / 1.70% |
LoseRVMD / S&P RVMD unavailable / 5.02% |
LoseRVMD / S&P RVMD unavailable / 0.21% |
| 2019-Q20/3 |
LoseRVMD / S&P RVMD unavailable / 4.30% |
LoseRVMD / S&P RVMD unavailable / 6.64% |
LoseRVMD / S&P RVMD unavailable / 8.65% |
| 2019-Q10/3 |
LoseRVMD / S&P RVMD unavailable / 13.65% |
LoseRVMD / S&P RVMD unavailable / 8.12% |
LoseRVMD / S&P RVMD unavailable / 14.29% |
| 2018-Q40/3 |
LoseRVMD / S&P RVMD unavailable / -13.52% |
LoseRVMD / S&P RVMD unavailable / 9.05% |
LoseRVMD / S&P RVMD unavailable / 18.23% |
| 2018-Q30/3 |
LoseRVMD / S&P RVMD unavailable / 7.71% |
LoseRVMD / S&P RVMD unavailable / 10.21% |
LoseRVMD / S&P RVMD unavailable / 19.06% |
| 2018-Q20/3 |
LoseRVMD / S&P RVMD unavailable / 3.43% |
LoseRVMD / S&P RVMD unavailable / 9.03% |
LoseRVMD / S&P RVMD unavailable / 14.46% |
| 2018-Q10/3 |
LoseRVMD / S&P RVMD unavailable / -0.76% |
LoseRVMD / S&P RVMD unavailable / 7.68% |
LoseRVMD / S&P RVMD unavailable / 12.46% |
| 2017-Q40/3 |
LoseRVMD / S&P RVMD unavailable / 6.64% |
LoseRVMD / S&P RVMD unavailable / 7.03% |
LoseRVMD / S&P RVMD unavailable / 13.82% |
| 2017-Q30/3 |
LoseRVMD / S&P RVMD unavailable / 4.48% |
LoseRVMD / S&P RVMD unavailable / 5.68% |
LoseRVMD / S&P RVMD unavailable / 17.57% |
| 2017-Q20/3 |
LoseRVMD / S&P RVMD unavailable / 3.09% |
LoseRVMD / S&P RVMD unavailable / 4.83% |
LoseRVMD / S&P RVMD unavailable / 17.74% |
| 2017-Q10/3 |
LoseRVMD / S&P RVMD unavailable / 6.07% |
LoseRVMD / S&P RVMD unavailable / 3.67% |
LoseRVMD / S&P RVMD unavailable / 13.32% |
| 2016-Q40/3 |
LoseRVMD / S&P RVMD unavailable / 3.82% |
LoseRVMD / S&P RVMD unavailable / 2.09% |
LoseRVMD / S&P RVMD unavailable / 7.05% |
| 2016-Q30/3 |
LoseRVMD / S&P RVMD unavailable / 3.85% |
LoseRVMD / S&P RVMD unavailable / 0.20% |
LoseRVMD / S&P RVMD unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | RVMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 482.43% | 20.78% |
| Annualized return | 482.43% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | RVMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 650.17% | 83.14% |
| Annualized return | 49.63% | 12.86% |
10Y · 2020-02-13 to 2026-08-27
| Metric | RVMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 665.22% | 319.30% |
| Annualized return | 22.57% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |